Media Summary: Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series. Michael Lehmicke, Senior Director of Science & Industry Affairs, Alliance for Regenerative Medicine, Washington, D.C., comments ... Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., discusses the ...

Navigate The Complexities Of Cell And Gene Therapies With Regulatory And Cmc Expertise - Detailed Analysis & Overview

Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series. Michael Lehmicke, Senior Director of Science & Industry Affairs, Alliance for Regenerative Medicine, Washington, D.C., comments ... Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., discusses the ... This is a recording of a presentation at the 2020 BPI Theater @ BIO. Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the role and future This panel will explore the evolving landscape of xenotransplantation, a type of regenerative medicine, including discussion of ...

Originally released in May 2024 A person considering a This workshop will feature leading executives who will discuss a number of topics surrounding CDMO networks including ... FEATURED TALK: FDA'S EFFORTS TO ADVANCE THE DEVELOPMENT AND APPROVAL OF

Photo Gallery

Navigate the complexities of cell and gene therapies with regulatory and CMC expertise
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series
CMC challenges in cell and gene therapy manufacturing
The challenges of CMC in cell and gene therapies
Regulation of Gene Therapies
Cell and gene therapy insights
Cell and Gene Therapy Clinical Trials: How to Successfully Operationalize a Trial
Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing
The future directions of EBMT: introduction of cellular and gene therapy
Shaping the future of CMC in cell & gene therapy
Overview of Standards Setting for Cell/Gene Therapies-- Case Studies
Xenotransplantation:  Future Opportunities, Challenges, & Available Guidance
Sponsored
Sponsored
View Detailed Profile
Navigate the complexities of cell and gene therapies with regulatory and CMC expertise

Navigate the complexities of cell and gene therapies with regulatory and CMC expertise

Learn why

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series.

Sponsored
CMC challenges in cell and gene therapy manufacturing

CMC challenges in cell and gene therapy manufacturing

Michael Lehmicke, Senior Director of Science & Industry Affairs, Alliance for Regenerative Medicine, Washington, D.C., comments ...

The challenges of CMC in cell and gene therapies

The challenges of CMC in cell and gene therapies

Mike Lehmicke, Director of Science & Industry Affairs, Alliance for Regenerative Medicine (ARM), Washington, D.C., discusses the ...

Regulation of Gene Therapies

Regulation of Gene Therapies

Gain an overview of the

Sponsored
Cell and gene therapy insights

Cell and gene therapy insights

Delve into the world of

Cell and Gene Therapy Clinical Trials: How to Successfully Operationalize a Trial

Cell and Gene Therapy Clinical Trials: How to Successfully Operationalize a Trial

Cell

Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing

Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing

This is a recording of a presentation at the 2020 BPI Theater @ BIO.

The future directions of EBMT: introduction of cellular and gene therapy

The future directions of EBMT: introduction of cellular and gene therapy

Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the role and future

Shaping the future of CMC in cell & gene therapy

Shaping the future of CMC in cell & gene therapy

Stephen Ward, PhD,

Overview of Standards Setting for Cell/Gene Therapies-- Case Studies

Overview of Standards Setting for Cell/Gene Therapies-- Case Studies

Overview of Standards Setting for

Xenotransplantation:  Future Opportunities, Challenges, & Available Guidance

Xenotransplantation: Future Opportunities, Challenges, & Available Guidance

This panel will explore the evolving landscape of xenotransplantation, a type of regenerative medicine, including discussion of ...

Community Quick Takes: Access to Approved Cell and Gene Therapies

Community Quick Takes: Access to Approved Cell and Gene Therapies

Originally released in May 2024 A person considering a

Regulatory considerations for Cell and Gene Therapies - Jim DeKloe

Regulatory considerations for Cell and Gene Therapies - Jim DeKloe

... for

Unlocking scalable cell and gene therapies | Team Consulting

Unlocking scalable cell and gene therapies | Team Consulting

The high cost and

The Future of CDMO Networks in Cell and Gene Therapy

The Future of CDMO Networks in Cell and Gene Therapy

This workshop will feature leading executives who will discuss a number of topics surrounding CDMO networks including ...

CMC for Cell and Gene Therapy Products

CMC for Cell and Gene Therapy Products

Dive into the World of

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FEATURED TALK: FDA'S EFFORTS TO ADVANCE THE DEVELOPMENT AND APPROVAL OF

2021 INC Annual Meeting | Session I | Cell and Gene Therapies

2021 INC Annual Meeting | Session I | Cell and Gene Therapies

Did you know that

Understand the Main CMC Challenges to Improve ATMP Development

Understand the Main CMC Challenges to Improve ATMP Development

Recent clinical successes in